menu Search
Novartis

DOCQUITY MALAYSIA

Marketer for Novartis
Accentrix
Accentrix soln for inj 10 mg/mL
ranibizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA04 - ranibizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Pagenax
Pagenax intraocular inj 120 mg/mL
brolucizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.